FDA Placed Severe Use Restrictions for Avandia
The FDA announced in September that they are placing severe restrictions on the continuing use and prescription of Avandia. The European Medicines Agency (Europe’s version of the FDA) went even further, banning the advertising, marketing, or sale of Avandia. Under the FDA’s restrictions, a doctor will have to certify that their patient has tried all other diabetes drugs without success. In addition, the patient will have to sign a detailed consent form outlining the cardiovascular risks associated with Avandia and any other available treatment options.